Cetirizine HCL

Cetirizine is an antihistamine that reduces the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose. It is used to treat cold or allergysymptoms such as sneezing, itching, watery eyes, or runny nose.

Cetirizine is also used to treat itching and swelling caused by hives.

Cetirizine may also be used for other purposes not listed in this medication guide.

 

Certificate of Analysis

  • Description

    White or almost white powder.

    Result

    White powder.

  • Solubility

    Freely soluble in water, practically insoluble in acetone & in Methylene chloride.

    Result

    Complies

  • Identification by IR

    Should match with the standard.

    Result

    Complies

  • Identification by Reaction of chlorides

    Should be complies.

    Result

    Complies

  • Identification by UV observance

    The specific absorbance at maximum is 359 to 381.

    Result

    Complies

  • Identification by TLC

    Should be complies.

    Result

    Complies

  • Appearance of Solution

    Solution S should be clear & not more than intensely coloured than reference solution BY 7

    Result

    Complies

  • pH

    Between 1.2 to 1.8

    Result

    1.61

  • Loss on Drying

    NMT : 0.50 % w/w

    Result

    0.23 % w/w

  • Heavy meals

    NMT : 10 ppm

    Result

    Less than 10 ppm

  • Sulphated Ash

    NMT : 0.2 % w/w

    Result

    0.09 % w/w

  • Assay (on dried basis)

    NLT : 99.0 % w/w & NMT : 100.5 % w/w

    Result

    99.53 % w/w

  • Related substance by HPLC Any single impurity / Total impurity

    NMT : 0.10 % / NMT : 0.30 %

    Result

    0.08 % / 0.26 %

Note: We are leading channel partner of much API manufacturer, supplier & exporters and Pharmaceutical raw material in Colombo, Chili, Ecuador and Globally.

Material Safety Data Sheet

  • Section 1 – Chemical Product

    Product Identifier

    Cetirizine HCL

    MSDS Prepared By

    R&D Department

  • Section 2 – Composition / Information Of Ingredients

    Product Name

    Cetirizine Dihydrochloride

    Synonym

    [2-]4-[(4-chlorophenyl) phenylmethy1] -1-piperaziny1] ethoxy] acetic acid dihydrochloride

    Molecular Formula

    C21H25Cl N2O3 2HCL

    Molecular Weight

    461.81

    CAS Number

    83881-52-1

  • Section 3 – HAZARDOUS IDENTIFICATION

    Potential acute health effects

    N/A

    Potential Chronic Health Effects

    Carcinogenic Effects

    N/A

    Mutagenic Effects

    N/A

    Teratogenic Effects

    N/A

    Development Toxicity

    N/A

  • Section 4 – FIRST AID

    Skin Contact

    Get medical attention if irritation develops and persists.

    Serious Skin Contact

    N/A

    Eye Contact

    Get medical attention if irritation develops and persists.

    Inhalation

    Move to fresh air. Call a POISON CENTER or doctor/physician if you feel unwell.

    Serious Inhalation

    N/A

    Ingestion

    IF SWALLOWED; Call a POISON CENTER or doctor/physician if you feel unwell. Rinse mouth thoroughly.

    Serious Ingestion

    N/A

  • Section 5 – FIRE FIGHTING MEASURES

    Flammability of the Product

    N/A

    Auto-ignition Temperature

    N/A

    Flash Point

    N/A

    Flammable Limits

    N/A

    Products of Combustion

    N/A

    Fire Hazards in presence of various substance

    N/A

    Risks of explosion of product in presence of mechanical impact

    N/A

    Risks of explosion of product in presence of static discharge

    N/A

    Special remarks on Fire Hazards

    N/A

    Fire Fighting Media & Instruction

    Small Fire

    Use DRY chemical powder.

    Large Fire

    Use water spray, fog or foam. Do not use water jet.

  • Section 6 – ACCEDIENTAL RELEASE MEASURES

    Small Spill

    N/A

    Large Spill

    N/A

  • Section 7 – HANDLING AND STORAGE

    Precautions

    As a general rule, when handling USO reference standards, avoid all contact and inhalation of dust, mists and/or vapors associated with the material. Clean equipment and work surfaces with suitable detergent or solvent after use. After removing gloves, wash hands and other exposed skin thoroughly.

    Storage

    Store in tight container as defined in the USP-NF. This material should be handled and stored per including any in compatibilities label instruction to ensure product integrity.

  • Section 8 – EXPOSURE CONTROLS / PERSONAL PROTECTION

    Engineering Controls

    Airborne exposure should be controlled primarily by engineering controls such as general dilution ventilation, local exhaust ventilation is generally preferred to general exhaust because it can control the contaminant at its source, preventing dispersion into the work area. An industrial hygiene survey involving air monitoring may be used to determine the effectiveness of engineering controls. Effectiveness of engineering controls intended for use with highly potent materials should be assessed by use of nontoxic surrogate materials.

    Personal Protection

    Eye Protection

    Safety glasses with side shields are recommended. Face shields or goggles may be required if splash potential exits or if corrosive materials are present. Approved eye protection is preferred. Maintain eyewash facilities in the work area.

    Hand Protection

    Chemically compatible gloves. For handling solutions, ensure that the glove material is protective against the solvent being used. Use handling practices that minimize direct hand contact. Employees who are sensitive to natural rubber should use nitrile or other synthetic non latex gloves. Use of powdered latex gloves should be avoided due to the risk of latex allergy.

    Respiratory Protection

    Where respiratory are deemed necessary to reduce or control Occupational exposure, use NIOSH-approved respiratory protection and have an effectiveness respiratory program in place.

    Other

    For handling of laboratory scale quantities, a cloth lab coat is recommended. Where significant quantities are handled, work clothing may be necessary to prevent take-home contamination.

    Exposure Limits

    N/A

  • Section 9 – PHYSICAL AND CHEMICAL PROPERITIES

    Physical State

    Solid & White crystalline powder.

    Color

    N/A

    Odor

    N/A

    Taste

    N/A

    ph

    1.2 – 1.8 (5% aqueous solution)

    Boiling Point

    N/A

    Melting Point

    437 F

    Critical Temperature

    N/A

    Specific Gravity

    N/A

    Vapour Pressure

    N/A

    Vapour Density

    N/A

    Volatility

    N/A

    Odor Threshold

    N/A

    Water / Oil Dist. Coeff

    N/A

    Iconicity (in water)

    N/A

    Dispersion Properties

    N/A

    Solubility

    Practically insoluble in acetone and in methylene chloride.

  • Section 10 – STABILITY AND REACTIVITY

    Stability

    The Product is stable

    Instability Temperature

    N/A

    Condition of Instability

    N/A

    Incompatibility with various substance

    Not known

    Corrosivity

    N/A

    Special Remarks on Corrosivity

    n/a

    Special Remarks on Reactivity

    n/a

    Polymerization

    N/A

  • Section 11 – TOXICOLOGICAL INFORMATION

    Route of Entry

    N/A

    Toxicity to Animals

    N/A

    Chronic Effects on Humans

    N/A

    Other Toxic Effects on Humans

    N/A

    Special Remarks on Toxicity to Animals

    N/A

    Special Remarks on chronic Effects on Humans

    N/A

    Special Remarks on other Toxicity effects to Humans

    N/A

  • Section 12 – ECOLOGICAL INFORMATION

    Ecotoxicity

    No ecotoxicity data noted for the ingredients.

    BOD5 and COD

    N/A

    Products of Biodegradation

    N/A

    Toxicity of the products Biodegradation

    N/A

    Special Remarks on the Products of Biodegradation

    N/A

  • Section 13 – DISPOSAL CONSIDERATION

    Waste Disposal

    Dispose of contents/container in accordance with local / regional / national / international regulations.

  • Section 14 – TRANSPORT INFORMATION

    DOT Classification

    Not regulated as a hazardous material by DOT.

    Identification

    N/A

    Special provision for Transports

    N/A

  • Section 15 – REGULATORY INFORMATION

    US classification and Label Text

    N/A

    US Regulatory Information

    N/A

    Canada Regulatory Information

    N/A

  • Section 16 – OTHER INFORMATION

    Global Pharma provides information contained herein in good faith but makes no representation as to its comprehensives or accuracy. This document is intended only as a guide to the appropriate precautionary handling of the material by a properly trained person using this product.

    Individuals receiving the information must exercise their independent judgment in determining its appropriateness for a particular purpose.

    GLOBAL PHARMA MAKES NO REPRESENTATIONS OR WARRANTIES, EITHER EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY WARRANTIES OR MERCHANTABILITY, FITNESS FOR A PARTICULER PURPOSE WITH RESPECT TO THE INFORMATION SET FORTH HEREIN OR THE PRODUCT WHICH THE INFORMATION REEFERS. GLOBAL PHARMA WILL NOT BE RESPONSIBLE FOR DAMAGES RESULTING FROM USE OF RELIANCE UPON THIS INFORMATION.

WhatsApp
+91 9819994077